Botox (OnabotulinumtoxinA) for Treatment of Migraine Symptoms: A Systematic Review

Botox (OnabotulinumtoxinA) for Treatment of Migraine Symptoms: A Systematic Review

Background. Migraine is one of the most common types of headache, and it is the second most common cause of neurological disorders, with an annual prevalence of about 15% of the population. This study aimed to evaluate the effect of BoNT-A on the duration and intensity of migraine attacks. In additi...

Full description

Saved in:
Bibliographic Details
Main Authors: Negar Shaterian, Negin Shaterian, Aref Ghanaatpisheh, Farnaz Abbasi, Sara Daniali, Maryam Jalali Jahromi, Mohammad Sadegh Sanie, Amir Abdoli
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Pain Research and Management
Online Access:http://dx.doi.org/10.1155/2022/3284446
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items